APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Arteriovenous Fistula Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Arteriovenous Fistula Treatment Market Outlook and Growth Opportunities 2026

Report ID 173967350421 December 2025190 pages

Choose your research edition.

Industry ResearchArteriovenous Fistula Treatment Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Arteriovenous Fistula Treatment Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Arteriovenous Fistula Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arteriovenous Fistula Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Arteriovenous Fistula Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Arteriovenous Fistula Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Arteriovenous Fistula Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Arteriovenous Fistula Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arteriovenous Fistula Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Arteriovenous Fistula Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Arteriovenous Fistula Treatment market include Teleflex Incorporated, Medtronic, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen Ag, Poly Medicure Limited, NxStage Medical, Cook Medical and Becton Dickinson, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Arteriovenous Fistula Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Arteriovenous Fistula Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Arteriovenous Fistula Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Arteriovenous Fistula Treatment market.

Arteriovenous Fistula Treatment Segment by Company

Teleflex Incorporated

Medtronic

Fresenius Medical Care AG & Co. KGaA

B. Braun Melsungen Ag

Poly Medicure Limited

NxStage Medical

Cook Medical

Becton Dickinson

Arteriovenous Fistula Treatment Segment by Type

Peripheral Arteriovenous Fistulas

Dural Arteriovenous Fistulas

Pial or Cerebral Arteriovenous Fistulas

Arteriovenous Fistula Treatment Segment by Application

Drugs

Surgery

Transcatheter Embolization

Ultrasound-guided Compression

Arteriovenous Fistula Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Arteriovenous Fistula Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Arteriovenous Fistula Treatment key companies, revenue, market share, and recent developments.

3. To split the Arteriovenous Fistula Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Arteriovenous Fistula Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Arteriovenous Fistula Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Arteriovenous Fistula Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arteriovenous Fistula Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arteriovenous Fistula Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arteriovenous Fistula Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Arteriovenous Fistula Treatment industry.

Chapter 3: Detailed analysis of Arteriovenous Fistula Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Arteriovenous Fistula Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Arteriovenous Fistula Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Arteriovenous Fistula Treatment Industry Trends Table 2. Arteriovenous Fistula Treatment Industry Drivers Table 3. Arteriovenous Fistula Treatment Industry Opportunities and Challenges Table 4. Arteriovenous Fistula Treatment Industry Restraints Table 5. Global Arteriovenous Fistula Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Arteriovenous Fistula Treatment Revenue Share by Company (2021-2026) Table 7. Global Arteriovenous Fistula Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Arteriovenous Fistula Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Arteriovenous Fistula Treatment Company, Product Type & Application Table 10. Global Arteriovenous Fistula Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Arteriovenous Fistula Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Peripheral Arteriovenous Fistulas Table 15. Significant Companies of Dural Arteriovenous Fistulas Table 16. Significant Companies of Pial or Cerebral Arteriovenous Fistulas Table 17. Global Arteriovenous Fistula Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Arteriovenous Fistula Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Arteriovenous Fistula Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Arteriovenous Fistula Treatment Sales Value Share by Type (2021-2026) Table 21. Global Arteriovenous Fistula Treatment Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Drugs Table 23. Significant Companies of Surgery Table 24. Significant Companies of Transcatheter Embolization Table 25. Significant Companies of Ultrasound-guided Compression Table 26. Global Arteriovenous Fistula Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Arteriovenous Fistula Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Arteriovenous Fistula Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Arteriovenous Fistula Treatment Sales Value Share by Application (2021-2026) Table 30. Global Arteriovenous Fistula Treatment Sales Value Share by Application (2027-2032) Table 31. Global Arteriovenous Fistula Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Arteriovenous Fistula Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Arteriovenous Fistula Treatment Sales Value Share by Region (2021-2026) Table 34. Global Arteriovenous Fistula Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Arteriovenous Fistula Treatment Sales Value Share by Region (2027-2032) Table 36. Global Arteriovenous Fistula Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Arteriovenous Fistula Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Arteriovenous Fistula Treatment Sales Value Market Share by Country (2021-2026) Table 39. Global Arteriovenous Fistula Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Arteriovenous Fistula Treatment Sales Value Market Share by Country (2027-2032) Table 41. Teleflex Incorporated Company Information Table 42. Teleflex Incorporated Business Overview Table 43. Teleflex Incorporated Arteriovenous Fistula Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Teleflex Incorporated Arteriovenous Fistula Treatment Product Portfolio Table 45. Teleflex Incorporated Recent Development Table 46. Medtronic Company Information Table 47. Medtronic Business Overview Table 48. Medtronic Arteriovenous Fistula Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Medtronic Arteriovenous Fistula Treatment Product Portfolio Table 50. Medtronic Recent Development Table 51. Fresenius Medical Care AG & Co. KGaA Company Information Table 52. Fresenius Medical Care AG & Co. KGaA Business Overview Table 53. Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Product Portfolio Table 55. Fresenius Medical Care AG & Co. KGaA Recent Development Table 56. B. Braun Melsungen Ag Company Information Table 57. B. Braun Melsungen Ag Business Overview Table 58. B. Braun Melsungen Ag Arteriovenous Fistula Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. B. Braun Melsungen Ag Arteriovenous Fistula Treatment Product Portfolio Table 60. B. Braun Melsungen Ag Recent Development Table 61. Poly Medicure Limited Company Information Table 62. Poly Medicure Limited Business Overview Table 63. Poly Medicure Limited Arteriovenous Fistula Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Poly Medicure Limited Arteriovenous Fistula Treatment Product Portfolio Table 65. Poly Medicure Limited Recent Development Table 66. NxStage Medical Company Information Table 67. NxStage Medical Business Overview Table 68. NxStage Medical Arteriovenous Fistula Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. NxStage Medical Arteriovenous Fistula Treatment Product Portfolio Table 70. NxStage Medical Recent Development Table 71. Cook Medical Company Information Table 72. Cook Medical Business Overview Table 73. Cook Medical Arteriovenous Fistula Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Cook Medical Arteriovenous Fistula Treatment Product Portfolio Table 75. Cook Medical Recent Development Table 76. Becton Dickinson Company Information Table 77. Becton Dickinson Business Overview Table 78. Becton Dickinson Arteriovenous Fistula Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Becton Dickinson Arteriovenous Fistula Treatment Product Portfolio Table 80. Becton Dickinson Recent Development Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Arteriovenous Fistula Treatment Product Image Figure 2. Global Arteriovenous Fistula Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arteriovenous Fistula Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Arteriovenous Fistula Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Peripheral Arteriovenous Fistulas Image Figure 8. Dural Arteriovenous Fistulas Image Figure 9. Pial or Cerebral Arteriovenous Fistulas Image Figure 10. Global Arteriovenous Fistula Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Arteriovenous Fistula Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Arteriovenous Fistula Treatment Sales Value Share by Type (2021-2032) Figure 13. Drugs Image Figure 14. Surgery Image Figure 15. Transcatheter Embolization Image Figure 16. Ultrasound-guided Compression Image Figure 17. Global Arteriovenous Fistula Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Arteriovenous Fistula Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Arteriovenous Fistula Treatment Sales Value Share by Application (2021-2032) Figure 20. Global Arteriovenous Fistula Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Arteriovenous Fistula Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Arteriovenous Fistula Treatment Sales Value (2021-2032) & (US$ Million) Figure 23. North America Arteriovenous Fistula Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Arteriovenous Fistula Treatment Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Arteriovenous Fistula Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Arteriovenous Fistula Treatment Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Arteriovenous Fistula Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Arteriovenous Fistula Treatment Sales Value (2021-2032) & (US$ Million) Figure 29. South America Arteriovenous Fistula Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Arteriovenous Fistula Treatment Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Arteriovenous Fistula Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Peripheral Arteriovenous Fistulas
  • Dural Arteriovenous Fistulas
  • Pial or Cerebral Arteriovenous Fistulas
Applications
  • Drugs
  • Surgery
  • Transcatheter Embolization
  • Ultrasound-guided Compression
Companies covered
  • Teleflex Incorporated
  • Medtronic
  • Fresenius Medical Care AG & Co. KGaA
  • B. Braun Melsungen Ag
  • Poly Medicure Limited
  • NxStage Medical
  • Cook Medical
  • Becton Dickinson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Arteriovenous Fistula Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Arteriovenous Fistula Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Arteriovenous Fistula Treatment Market Dynamics
  1. 2.1 Arteriovenous Fistula Treatment Industry Trends
  2. 2.2 Arteriovenous Fistula Treatment Industry Drivers
  3. 2.3 Arteriovenous Fistula Treatment Industry Opportunities and Challenges
  4. 2.4 Arteriovenous Fistula Treatment Industry Restraints
3 Arteriovenous Fistula Treatment Market by Company
  1. 3.1 Global Arteriovenous Fistula Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Arteriovenous Fistula Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Arteriovenous Fistula Treatment Company Ranking (2024-2026)
  4. 3.4 Global Arteriovenous Fistula Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Arteriovenous Fistula Treatment Company Product Type and Application
  6. 3.6 Global Arteriovenous Fistula Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Arteriovenous Fistula Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Arteriovenous Fistula Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Arteriovenous Fistula Treatment Market by Type
  1. 4.1 Arteriovenous Fistula Treatment Type Introduction
  2. 4.1.1 Peripheral Arteriovenous Fistulas
  3. 4.1.2 Dural Arteriovenous Fistulas
  4. 4.1.3 Pial or Cerebral Arteriovenous Fistulas
  5. 4.2 Global Arteriovenous Fistula Treatment Sales Value by Type
  6. 4.2.1 Global Arteriovenous Fistula Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Arteriovenous Fistula Treatment Sales Value by Type (2021-2032)
  8. 4.2.3 Global Arteriovenous Fistula Treatment Sales Value Share by Type (2021-2032)
5 Arteriovenous Fistula Treatment Market by Application
  1. 5.1 Arteriovenous Fistula Treatment Application Introduction
  2. 5.1.1 Drugs
  3. 5.1.2 Surgery
  4. 5.1.3 Transcatheter Embolization
  5. 5.1.4 Ultrasound-guided Compression
  6. 5.2 Global Arteriovenous Fistula Treatment Sales Value by Application
  7. 5.2.1 Global Arteriovenous Fistula Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Arteriovenous Fistula Treatment Sales Value by Application (2021-2032)
  9. 5.2.3 Global Arteriovenous Fistula Treatment Sales Value Share by Application (2021-2032)
6 Arteriovenous Fistula Treatment Regional Value Analysis
  1. 6.1 Global Arteriovenous Fistula Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Arteriovenous Fistula Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Arteriovenous Fistula Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Arteriovenous Fistula Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Arteriovenous Fistula Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Arteriovenous Fistula Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Arteriovenous Fistula Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Arteriovenous Fistula Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Arteriovenous Fistula Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Arteriovenous Fistula Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Arteriovenous Fistula Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Arteriovenous Fistula Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Arteriovenous Fistula Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Arteriovenous Fistula Treatment Sales Value Share by Country, 2025 VS 2032
7 Arteriovenous Fistula Treatment Country-level Value Analysis
  1. 7.1 Global Arteriovenous Fistula Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Arteriovenous Fistula Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Arteriovenous Fistula Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Arteriovenous Fistula Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Arteriovenous Fistula Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Arteriovenous Fistula Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Arteriovenous Fistula Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teleflex Incorporated
  2. 8.1.1 Teleflex Incorporated Company Information
  3. 8.1.2 Teleflex Incorporated Business Overview
  4. 8.1.3 Teleflex Incorporated Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teleflex Incorporated Arteriovenous Fistula Treatment Product Portfolio
  6. 8.1.5 Teleflex Incorporated Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Arteriovenous Fistula Treatment Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 Fresenius Medical Care AG & Co. KGaA
  14. 8.3.1 Fresenius Medical Care AG & Co. KGaA Company Information
  15. 8.3.2 Fresenius Medical Care AG & Co. KGaA Business Overview
  16. 8.3.3 Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Product Portfolio
  18. 8.3.5 Fresenius Medical Care AG & Co. KGaA Recent Developments
  19. 8.4 B. Braun Melsungen Ag
  20. 8.4.1 B. Braun Melsungen Ag Company Information
  21. 8.4.2 B. Braun Melsungen Ag Business Overview
  22. 8.4.3 B. Braun Melsungen Ag Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 B. Braun Melsungen Ag Arteriovenous Fistula Treatment Product Portfolio
  24. 8.4.5 B. Braun Melsungen Ag Recent Developments
  25. 8.5 Poly Medicure Limited
  26. 8.5.1 Poly Medicure Limited Company Information
  27. 8.5.2 Poly Medicure Limited Business Overview
  28. 8.5.3 Poly Medicure Limited Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Poly Medicure Limited Arteriovenous Fistula Treatment Product Portfolio
  30. 8.5.5 Poly Medicure Limited Recent Developments
  31. 8.6 NxStage Medical
  32. 8.6.1 NxStage Medical Company Information
  33. 8.6.2 NxStage Medical Business Overview
  34. 8.6.3 NxStage Medical Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NxStage Medical Arteriovenous Fistula Treatment Product Portfolio
  36. 8.6.5 NxStage Medical Recent Developments
  37. 8.7 Cook Medical
  38. 8.7.1 Cook Medical Company Information
  39. 8.7.2 Cook Medical Business Overview
  40. 8.7.3 Cook Medical Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cook Medical Arteriovenous Fistula Treatment Product Portfolio
  42. 8.7.5 Cook Medical Recent Developments
  43. 8.8 Becton Dickinson
  44. 8.8.1 Becton Dickinson Company Information
  45. 8.8.2 Becton Dickinson Business Overview
  46. 8.8.3 Becton Dickinson Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Becton Dickinson Arteriovenous Fistula Treatment Product Portfolio
  48. 8.8.5 Becton Dickinson Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst